Abstract:Sornsiri Yimlamai, Kanokpan Ruangnapa, Wanaporn Anuntaseree, Kantara Saelim, Pharsai Prasertsan, Kantisa Sirianansopa Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand Correspondence: Kanokpan Ruangnapa, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat-Yai, Songkhla, 90110, Thailand, Tel +66-74-451250-1, Fax +66-74-451250-3, Email Purpose: It is still unclear whether considering abnormal spirometry as a marker for disease control can help physicians adjust asthma controllers in children because of the scarcity of pediatric studies. We aimed to investigate the prevalence of abnormal spirometry in a selected pediatric asthmatic population and its effect on longitudinal outcomes. Patients and Methods: This retrospective cohort study was conducted at the Songklanagarind Hospital, Thailand. Children with asthma aged < 18 years were recruited for review if they attended the clinic and underwent acceptable spirometry with bronchodilator responsiveness (BDR) tests after receiving asthma treatment for at least 3 months between January 2011 and June 2022. Differences in baseline characteristics, atopic factors, asthma treatment, and outcomes were analyzed between the normal and abnormal spirometry groups over a 12-month post-spirometry period. Results: The mean age of the 203 enrolled patients was 10.9 ± 2.6 years. Abnormal spirometry, defined as airflow limitation or the presence of BDR, was observed in 58.1% of patients. No significant differences were observed in baseline characteristics, atopic factors, asthma treatment, or outcomes between the normal and abnormal spirometry groups. Further analysis of 107 patients with abnormal spirometry with symptom control revealed that physicians adjusted the asthma controller based on spirometry and symptoms in 84 and 23 patients, respectively. There was no significant difference in the loss of disease control over the 12-month post-spirometry period between the two groups. Conclusion: Abnormal spirometry was found in 58.1% of treated school-aged patients with asthma. Abnormal spirometry results were not associated with poor asthma outcomes during the 12-month follow-up. Both symptom-based and spirometry-based adjustments of asthma controllers resulted in comparable symptom control over a 12-month follow-up period in the selected population. Keywords: pulmonary function test, lung function test, childhood asthma, bronchodilator responsiveness Asthma is the most prevalent non-communicable respiratory disease in childhood, affecting 11–13% of children worldwide. 1 Besides symptom control and minimizing the future risk of exacerbations, preserving normal lung function is an important goal of long-term pediatric asthma care. 2 Impaired lung function in children with asthma is associated with an increased risk of chronic airflow obstruction and chronic obstructive pulmonary disease development in early adulthood. 2–4 Therefore, regular assessment of lung function is encouraged in monitoring children with asthma. 2,5 Spirometry is currently the standard tool for assessing lung function in children with asthma. Abnormal spirometry parameters (such as low forced expiratory volume in 1 s [FEV1], low ratio of FEV1 to forced vital capacity [FEV1/FVC], or low forced expiratory flow between 25% and 75% of vital capacity [FEF25–75%], which represents airway dysfunction), are considered predictors of disease severity and long-term prognosis of respiratory health. 3,4 Children with asthma with a lower FEV1 percentage are more likely to have more severe disease and are at a higher risk of exacerbation. 6,7 However, a significant portion of symptom-controlled patients with asthma still have abnormal lung function. 8–11 Airway reversibility is another characteristic feature of asthma that can be assessed via bronchodilator responsiveness (BDR) testing in children with asthma. 2,5 Besides its diagnostic purpose, the persistence of BDR is a marker of poor asthma control and predictive of a good response to inhaled corticosteroids (ICS). 12,13 Previous studies have reported evidence of airway reversibility in children with asthma with good asthma control or normal lung function. 14,15 These controversial findings affect the role of spirometry and BDR testing in asthma management. However, because of the scarcity of pediatric studies, it is still unclear whether, besides symptom assessment, considering abnormal lung function or the presence of BDR as another marker for disease control can help physicians adjust asthma controllers in children. Hence, we aimed to investigate the prevalence of abnormal spirometry results in -Abstract Truncated-

Lung function trajectories and bronchial hyperresponsiveness during childhood following severe RSV bronchiolitis in infancy

Epidemiological Characteristics and Immune Status of Children with Respiratory Syncytial Virus.

Recurrent Wheezing and Asthma after Respiratory Syncytial Virus Bronchiolitis

Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases

Age‐specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5 years of age

Determinants of lung function development from birth to age 5 years: an interrupted time series analysis of a South African birth cohort

Distinct trajectories of lung function from childhood to mid-adulthood

RSV‐hRV co‐infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis

Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection

Asthma and health-related quality of life at 16–20 years of age in a prospectively followed post-bronchiolitis cohort

Immunity to RSV in Early-Life

Prognosis of bronchial asthma in children with different pulmonary function phenotypes: A real-world retrospective observational study

Reduced Lung Function at Preschool Age in Survivors of Very Low Birth Weight Preterm Infants

Lung function trajectories in children with early diagnosis of non-cystic fibrosis bronchiectasis: a retrospective observational study

A Longitudinal Study of a Selected Pediatric Asthmatic Population with Normal and Abnormal Spirometry at Baseline: An Emphasis on Treatment Outcomes

Respiratory syncytial virus infections: old challenges and new opportunities

Bronchodilator Dose Responsiveness in Children and Adolescents: Clinical Features and Association with Future Asthma Exacerbations

Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at 6 years of age

Bronchiolitis hospitalizations in rural New England: clues to disease prevention

Long term follow-up of Palivizumab administration in children born at 29-32 weeks of gestation

Severe bronchial hyperresponsiveness along with house dust mite allergy indicates persistence of asthma in young children